Simultaneous T 2 , T 2 *, and R 2
Jose Raul Velasquez Vides, Carl J. J. Herrmann, Thomas Gladytz, Hoby P. Hetherington, Hendrik Mattern, Xiaoqing Wang, Jason M. Millward, Shahriar Shalikar, Igor Fabian Tellez Ceja, Beate Endemann, Sonia Waiczies, Joseph Kuchling, Friedemann Paul, Georg Rose, Min‐Chi Ku, Franz Schmitt, Thoralf NiendorfABSTRACT
Purpose
To demonstrate the synergy of undersampled radial 2in1‐RARE‐EPI acquisition and nonlinear model‐based reconstruction for accelerated and simultaneous T 2 , T 2 *, and R 2 ′ mapping in brains of patients with multiple sclerosis (MS).
Methods
2in1‐RARE‐EPI combines a RARE module with an EPI module to capture T 2 and T 2 * information. Nonlinear model‐based reconstruction was applied to estimate T 2 , T 2 * maps directly from undersampled k ‐space data. A retrospective undersampling experiment was conducted to compare nonlinear model‐based and parallel imaging compressed sensing (PICS) reconstruction. The proposed approach was validated and compared to reference methods multiecho spin‐echo ( T 2 , MSE) and multiecho gradient‐echo ( T 2 *, MGRE) in a phantom, healthy subjects, and MS patients.
Results
2in1‐RARE‐EPI together with nonlinear model‐based reconstruction enabled T 2 , T 2 *, and R 2 ′ mapping with 7.5‐fold scan‐time acceleration relative to the references, while addressing key limitations of reference techniques, including long acquisition times, misregistration, motion and off‐resonance sensitivity, and the need for calibration scans. Phantom and in vivo validation showed that the parametric maps obtained with this approach were in agreement with the reference methods. Compared with PICS, nonlinear model‐based reconstruction showed more consistent spatial detail and accuracy at higher acceleration factors. The proposed method detected small focal lesions in T 2 , T 2 *, and R 2 ′ maps of MS patients and enabled visualization of the central vein sign.
Conclusion
Scan time reduction facilitated by nonlinear model‐based reconstruction of 2in1‐RARE‐EPI provides a technical foundation for enhanced patient compliance, and is a fundamental precursor for broader clinical studies on the potential of T 2 , T 2 *, and R 2 ′ as imaging biomarkers.